FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.2400
-0.0090 (-3.61%)
Dec 29, 2025, 1:52 PM EST - Market open
FibroBiologics Market Cap
FibroBiologics has a market cap or net worth of $14.71 million as of December 29, 2025. Its market cap has decreased by -82.32% in one year.
Market Cap
14.71M
Enterprise Value
17.51M
1-Year Change
-82.32%
Ranking
Category
Stock Price
$0.24
Market Cap Chart
Since January 31, 2024, FibroBiologics's market cap has decreased from $945.52M to $14.71M, a decrease of -98.44%. That is a compound annual growth rate of -88.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 15.26M | -78.25% |
| Dec 31, 2024 | 70.17M | -92.58% |
| Jan 31, 2024 | 945.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.00B |
| Johnson & Johnson | 500.24B |
| AbbVie | 406.46B |
| UnitedHealth Group | 300.58B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 265.03B |
| Novo Nordisk | 232.28B |